×
References
Vijayalakshmi P, Anuradha R, Prakash K et al. Rubella serosurveys at three Aravind Eye Hospitals in Tamil Nadu, India. Bull World Health Organ. 2004;82(4):259-64.
Yadav S, Thukral R, Chakarvarti A. Comparative evaluation of measles, mumps & rubella vaccine at 9 & 15 months of age. Indian J Med Res. 2003;118:183-6.
Aksit S, Egemen A, Ozacar T et al. Rubella seroprevalence in an unvaccinated population in Izmir: recommendations for rubella vaccination in Turkey. Pediatr Infect Dis J. 1999;18(7):577-80.
Su SB, Guo HR. Seroprevalence of rubella among women of childbearing age in Taiwan after nationwide vaccination. Am J Trop Med Hyg. 2002;67(5):549-53.
Karakoc GB, Altintas DU, Kilinc B et al. Seroprevalence of rubella in school girls and pregnant women. Eur J Epidemiol. 2003;18(1):81-4.
Bukbuk DN, el Nafaty AU, Obed JY. Prevalence of rubella-specific IgG antibody in non-immunized pregnant women in Maiduguri, north eastern Nigeria. Cent Eur J Public Health. 2002 ;10(1-2):21-3.
Bhaskaram P, Ramalakshmi BA, Raju LA et al. Need for protection against rubella in India. Indian J Pediatr. 1991;58(6):811-4.
Chan PK, Li CY, Tam JS et al. Rubella immune status among healthcare workers in the Department of Obstetrics and Gynaecology of a regional hospital in Hong Kong: the need for a vaccination policy. J Hosp Infect. 1999;42(3):239-42.
Palihawadana P, Wickremasinghe AR, Perera J. Seroprevalence of rubella antibodies among pregnant females in Sri Lanka. Southeast Asian J Trop Med Public Health. 2003;34(2):398-404.
Cutts FT, Robertson SE, Diaz-Ortega JL, Samuel R. Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 1: Burden of disease from CRS. Bull World Health Organ. 1997;75(1):55-68.
Core information for the development of Immunization Policy. WHO- Vaccines and Biologicals. 2002 Update